Leclanché SA implements resolutions of the 2014 Annual Shareholders' Meeting

- CHF 10.7 million Precept convertible loan will be converted into ordinary shares

- The new shares will be listed on SIX Swiss Exchange as of April 15, 2014

Yverdon-les-Bains, Switzerland, April 14, 2014 - Leclanché S.A. (SIX Swiss Exchange: LECN), specialized in the production of large-format lithium-ion cells and energy storage solutions, announced today that the share capital reduction through the reduction of the nominal value of all outstanding registered shares from CHF 2.11 to CHF 1.50 and the concurrent re-increase of the share capital by way of an ordinary capital increase as resolved by the Annual Shareholders' Meeting of April 3, 2014 has been executed and duly registered with the Commercial Register of the Canton of Vaud.

Pursuant to the ordinary capital increase, 7,135,855 new shares were issued to Precept Fund Management SPC on behalf of Precept Fund Segregated Portfolio ("Precept") representing the conversion into equity in the equivalent amount of CHF 10,703,783 due under the loan granted by Precept dated July 8, 2013. The new shares are expected to commence trading on SIX Swiss Exchange on April 15, 2014. The security number, ISIN and the ticker symbol remain unchanged.

Leclanché S.A.'s new registered share capital amounts to CHF 30,765,622 and is divided into 20,510,622 fully paid-in registered shares with a nominal value of CHF 1.50 each.

About Leclanché

Leclanché's strategy is to become one of the leading lithium-ion cell producers and solution providers for energy storage systems in Europe. Its strategic priorities are to develop and market energy storage products for home, industrial markets and grid applications and to grow its existing businesses of developing portable energy storage systems for military, medical and industrial applications. It also includes providing a range of professional energy storage systems to a diversified customer base. Through participation in research consortia focusing on hybrid and E-mobility applications, Leclanché is positioned to take advantage of new market opportunities.

Through a unique, patented ceramic separator technology and focus on lithium-titanate technology, Leclanché manufactures large-format lithium-ion cells, optimized for safety and cycle-life, in a fully automated production process. The newly installed production line will have an annual capacity of one million cells or 76 MWh.

Leclanché was founded in 1909 in Yverdon-les-Bains. Through the integration of a spin-off from the Fraunhofer-Gesellschaft in 2006, the company evolved from a traditional battery manufacturer to become a leading developer and manufacturer of lithium-ion cells in Europe. Leclanché currently employs more than 100 staff and is listed on the SIX Swiss Exchange (LECN). The company has its headquarters in Yverdon-les-Bains (Switzerland) and production facilities in Willstätt (Germany).

www.leclanche.eu

Media contact:

Christophe Lamps, Dynamics Group S.A.: Telephone: +41 79 476 26 87, cla@dynamicsgroup.ch

Disclaimer

This press release contains certain forward-looking statements relating to Leclanché's business, which can be identified by terminology such as "strategic", "proposes", "to introduce", "will", "planned", "expected", "commitment", "expects", "set", "preparing", "plans", "estimates", "aims", "would", "potential", "awaiting", "estimated", "proposal", or similar expressions, or by expressed or implied discussions regarding the ramp up of Leclanché's production capacity, potential applications for existing products, or regarding potential future revenues from any such products, or potential future sales or earnings of Leclanché or any of its business units. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Leclanché regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Leclanché's products will achieve any particular revenue levels. Nor can there be any guarantee that Leclanché, or any of the business units, will achieve any particular financial results.